Case series of 406 vernal keratoconjunctivitis patients: a demographic and epidemiological study.

PURPOSE To evaluate the specific allergic sensitization and epidemiological characteristics of vernal keratoconjunctivitis (VKC). METHODS This retrospective non-comparative case series included 406 VKC patients. Data included patient and family histories, and results of allergic tests. Annual incidence and prevalence rates were calculated for a cohort of 128 VKC patients from the greater Padua area. RESULTS The great majority of VKC patients were male (76%), with a male : female ratio of 3.3 : 1. A skin prick test, specific serum IgE or conjunctival challenge was positive in 43%, 56% and 58% of patients, respectively. In the cohort of patients from the Padua area, the prevalence of the disease was 7.8/100,000, with a higher rate in young males (57/100,000) compared with young females (22/100,000), and lower rates in people over 16 years of age (3.8/100,000 in males, 1/100,000 in females). The incidence of VKC was 1/100,000, with a higher rate in males under 16 years of age (10/100,000) compared with females (4.2/100,000). In people over 16 years of age, the incidence of the disease was 0.06/100,000, with no difference between males and females. CONCLUSION An IgE-mediated sensitization was found in only half of the VKC patients. Vernal keratoconjunctivitis is not a rare event in the paediatric population but is an extremely rare new disease in adults.

[1]  L. Missotten,et al.  The T-lymphocyte chemoattractant Mig is highly expressed in vernal keratoconjunctivitis. , 2003, American journal of ophthalmology.

[2]  C. Ukponmwan.  Vernal Keratoconjunctivitis in Nigerians: 109 Consecutive Cases , 2003, Tropical doctor.

[3]  P. Jose,et al.  Tear and mucus eotaxin-1 and eotaxin-2 in allergic keratoconjunctivitis. , 2003, Ophthalmology.

[4]  Santa Jeremy Ono.  Vernal keratoconjunctivitis: evidence for immunoglobulin E‐dependent and immunoglobulin E‐independent eosinophilia , 2003, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[5]  E. Novembre,et al.  Atopy and serum eosinophil cationic protein in 110 white children with vernal keratoconjunctivitis: differences between tarsal and limbal forms , 2003, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[6]  A. Scheynius,et al.  Similar T helper Th2‐like cytokine mRNA expression in vernal keratoconjunctivitis regardless of atopic constitution , 2002, Allergy.

[7]  A. Leonardi.  Vernal keratoconjunctivitis: pathogenesis and treatment , 2002, Progress in Retinal and Eye Research.

[8]  L. Missotten,et al.  Expression of CD23/ CD21 and CD40/CD40 ligand in vernal keratoconjunctivitis , 2001, Eye.

[9]  L. Missotten,et al.  Chemokines in the limbal form of vernal keratoconjunctivitis , 2000, The British journal of ophthalmology.

[10]  P. Pasqualetti,et al.  Vernal keratoconjunctivitis revisited: a case series of 195 patients with long-term followup. , 2000, Ophthalmology.

[11]  J. G. O'shea.  A survey of vernal keratoconjunctivitis and other eosinophil-mediated external eye diseases amongst Palestinians , 2000, Ophthalmic epidemiology.

[12]  M. Plebani,et al.  Identification of local Th2 and Th0 lymphocytes in vernal conjunctivitis by cytokine flow cytometry. , 1999, Investigative ophthalmology & visual science.

[13]  A. Hjern,et al.  Vernal keratoconjunctivitis in a Stockholm ophthalmic centre--epidemiological, functional, and immunologic investigations. , 1999, Acta ophthalmologica Scandinavica.

[14]  Calder,et al.  Cytokine production and mRNA expression by conjunctival T‐cell lines in chronic allergic eye disease , 1999, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[15]  S. Tuft,et al.  Limbal vernal keratoconjunctivitis in the tropics. , 1998, Ophthalmology.

[16]  A. Lambiase,et al.  Estrogen and progesterone receptors in vernal keratoconjunctivitis. , 1995, Ophthalmology.

[17]  A. Scheynius,et al.  IgE, IgE receptors, and other immunocytochemical markers in atopic and nonatopic patients with vernal keratoconjunctivitis. , 1995, Ophthalmology.

[18]  J. Blalock,et al.  The syntax of immune-neuroendocrine communication. , 1994, Immunology today.

[19]  M. Battista,et al.  Antigen sensitivity evaluated by tear-specific and serum-specific IgE, skin tests, and conjunctival and nasal provocation tests in patients with ocular allergic disease , 1993, Eye.

[20]  M. de Carli,et al.  Accumulation of Th-2-like helper T cells in the conjunctiva of patients with vernal conjunctivitis. , 1991, Journal of immunology.

[21]  T. McMoli,et al.  Limbal vernal kerato-conjunctivitis in Yaounde, Cameroon. A clinico-immunology study. , 1991, Revue internationale du trachome et de pathologie oculaire tropicale et subtropicale et de sante publique : organe de la Ligue contre le trachome avec la collaboration de l'International Organization against Trachoma et des organisation....

[22]  S. Tuft,et al.  Limbal vernal keratoconjunctivitis: Clinical characteristics and immunoglobulin E expression compared with palpebral vernal , 1989, Eye.

[23]  N. Saeed,et al.  Incidence of keratoconus in spring catarrh. , 1988, The British journal of ophthalmology.

[24]  D. Sompolinsky,et al.  Allergen-specific immunoglobulin E antibodies in tears and serum of vernal conjunctivitis patients. , 1984, International archives of allergy and applied immunology.

[25]  L. Mendelson,et al.  Specific immunoglobulin E antibodies in tear secretions of patients with vernal conjunctivitis. , 1980, The Journal of allergy and clinical immunology.

[26]  I. C. Michaelson,et al.  A review of four hundred cases of vernal conjunctivitis. , 1959, American journal of ophthalmology.